MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma

Cancer Letters

Volumn 366, Issue 1, 2015, Pages 123-132

  Beckers, Anneleen ^a   Van Peer, Gert ^a   Carter, Daniel R ^b   Gartlgruber, Moritz ^c   Herrmann, Carl ^c,d   Agarwal, Saurabh ^e   Helsmoortel, Hetty H ^a   Althoff, Kristina ^f,g   Molenaar, Jan J ^h   Cheung, Belamy B ^b   Schulte, Johannes H ^c,f,g,i   Benoit, Yves ^a   Shohet, Jason M ^e   Westermann, Frank ^c   Marshall, Glenn M ^b   Vandesompele, Jo ^a   De Preter, Katleen ^a   Speleman, Frank ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b University of New South Wales Sydney   (Australia)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e CENTER FOR CELL AND GENE THERAPY   (United States)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g German Consortium for Translational Cancer Research (DKTK)   (Germany)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cross species; Integrative analysis; MicroRNA

Indexed keywords

LIN28B PROTEIN, HUMAN; MICRORNA; MIRN26A MICRORNA, HUMAN; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; RNA BINDING PROTEIN;

GENETIC TRANSCRIPTION; GENETICS; HUMAN; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; MICRORNAS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84937513731     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.06.015     Document Type: Article

References (39)

1. van de Bunt M., Gaulton K.J., Parts L., Moran I. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS ONE 2013, 8:e55272. 10.1371/journal.pone.0055272.
2. Shyh-Chang N., Daley G.Q. Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell 2013, 12:395-406. 10.1016/j.stem.2013.03.005.
3. Molenaar J.J., Domingo-Fernández R., Ebus M.E., Lindner S., Koster J., Drabek K., et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat. Genet 2012, 44:1199-1206. 10.1038/ng.2436.
4. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141. 10.1016/j.cell.2010.03.009.
5. Helwak A., Kudla G., Dudnakova T., Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013, 153:654-665. 10.1016/j.cell.2013.03.043.
6. Johnson C.D., Esquela-Kerscher A., Stefani G., Byrom M., Kelnar K., Ovcharenko D., et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007, 67:7713-7722. 10.1158/0008-5472.CAN-07-1083.
7. Liang L., Wong C.-M., Ying Q., Fan D.N.-Y., Huang S., Ding J., et al. MicroRNA-125b suppressed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 2010, 52:1731-1740. 10.1002/hep.23904.
8. Guo Y., Chen Y., Ito H., Watanabe A., Ge X., Kodama T., et al. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 2006, 384:51-61. 10.1016/j.gene.2006.07.011.
9. Helland Å., Anglesio M.S., George J., Cowin P.A., Johnstone C.N., House C.M., et al. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS ONE 2011, 6:e18064. 10.1371/journal.pone.0018064.
10. Cotterman R., Knoepfler P.S. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS ONE 2009, 4:e5799. 10.1371/journal.pone.0005799.g006.
11. Van Peer G., Lefever S., Anckaert J., Beckers A., Rihani A., Van Goethem A., et al. miRBase Tracker: keeping track of microRNA annotation changes. Database 2014, 2014:bau080. 10.1093/database/bau080.
12. Grimson A., Farh K.K.-H., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105. 10.1016/j.molcel.2007.06.017.
13. Wang X., El Naqa I.M. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008, 24:325-332. 10.1093/bioinformatics/btm595.
14. Muth D., Ghazaryan S., Eckerle I., Beckett E., Pöhler C., Batzler J., et al. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma. Cancer Res 2010, 70:3791-3802. 10.1158/0008-5472.CAN-09-1245.
15. Schulte J.H., Horn S., Otto T., Samans B., Heukamp L.C., Eilers U.-C., et al. MYCN regulates oncogenic microRNAs in neuroblastoma. Int. J. Cancer 2008, 122:699-704. 10.1002/ijc.23153.
16. Shohet J.M., Ghosh R., Coarfa C., Ludwig A., Benham A., Chen Z., et al. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Cancer Res 2011, 71:3841-3851. 10.1158/0008-5472.CAN-10-4391.
17. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem 2009, 55:611-622. 10.1373/clinchem.2008.112797.
18. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007, 8:R19. 10.1186/gb-2007-8-2-r19.
19. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:R34.
20. Hsu S.-D., Tseng Y.-T., Shrestha S., Lin Y.-L., Khaleel A., Chou C.-H., et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 2014, 42:D78-D85. 10.1093/nar/gkt1266.
21. Chi S.W., Zang J.B., Mele A., Darnell R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486. 10.1038/nature08170.
22. Mestdagh P., Lefever S., Pattyn F., Ridzon D., Fredlund E., Fieuw A., et al. The microRNA body map: dissecting microRNA function through integrative genomics. Nucleic Acids Res 2011, 39:e136. 10.1093/nar/gkr646.
23. Mestdagh P., Fredlund E., Pattyn F., Schulte J.H., Muth D., Vermeulen J., et al. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene 2010, 29:1394-1404. 10.1038/onc.2009.429.
24. Althoff K., Beckers A., Bell E., Nortmeyer M., Thor T., Sprüssel A., et al. A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. Oncogene 2014, 34:3357-3368. 10.1038/onc.2014.269.
25. Chang T.-C., Zeiteis L.R., Hwang H.-W., Chivukula R.R., Wentzel E.A., Dews M., et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3384-3389. 10.1073/pnas.0808300106.
26. You X., Liu F., Zhang T., Lv N., Liu Q., Shan C., et al. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells. Oncogene 2014, 33:449-460. 10.1038/onc.2012.618.
27. Cotterman R., Jin V.X., Krig S.R., Lemen J.M., Wey A., Farnham P.J., et al. N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cancer Res 2008, 68:9654-9662. 10.1158/0008-5472.CAN-08-1961.
28. Garzon R., Calin G.A., Croce C.M. MicroRNAs in cancer. Annu. Rev. Med 2009, 60:167-179. 10.1146/annurev.med.59.053006.104707.
29. Di Leva G., Garofalo M., Croce C.M. MicroRNAs in cancer. Annu. Rev. Pathol 2014, 9:287-314. 10.1146/annurev-pathol-012513-104715.
30. Rybak A., Fuchs H., Smirnova L., Brandt C., Pohl E.E., Nitsch R., et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat. Cell Biol 2008, 10:987-993. 10.1038/ncb1759.
31. Calin G.A., Croce C.M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006, 66:7390-7394. 10.1158/0008-5472.CAN-06-0800.
32. Peltier H.J., Latham G.J. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008, 14:844-852. 10.1261/rna.939908.
33. Chang K., Mestdagh P., Vandesompele J., Kerin M.J., Miller N. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 2010, 10:173. 10.1186/1471-2407-10-173.
34. Tan S., Ding K., Li R., Zhang W., Li G., Kong X., et al. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2. Breast Cancer Res 2014, 16:R40. 10.1186/bcr3644.
35. Zhu Y., Lu Y., Zhang Q., Liu J.-J., Li T.-J., Yang J.-R., et al. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res 2012, 40:4615-4625. 10.1093/nar/gkr1278.
36. Zhao X., Lwin T., Zhang X., Huang A., Wang J. Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity. Leukemia 2013, 27:2341-2350. 10.1038/leu.2013.94.
37. Zhang Z., Zha Y., Hu W., Huang Z., Gao Z., Zang Y., et al. The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J. Biol. Chem 2013, 288:37082-37093. 10.1074/jbc.M113.517953.
38. Hwang H.-W., Wentzel E.A., Mendell J.T. A hexanucleotide element directs microRNA nuclear import. Science 2007, 315:97-100. 10.1126/science.1136235.
39. Krol J., Busskamp V., Markiewicz I., Stadler M.B., Ribi S., Richter J., et al. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 2010, 141:618-631. 10.1016/j.cell.2010.03.039.